Machado-Joseph disease type 1

ORPHA: 276238

Overview

Machado-Joseph disease type 1 is a rare, usually severe subtype of Machado-Joseph disease (SCA3/MJD, see this term) characterized by the presence of marked pyramidal and extrapyramidal signs

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with Machado-Joseph disease type 1, sourced from HPO and Orphanet clinical annotations.

Progressive external ophthalmoplegiaDystoniaAbnormality of extrapyramidal motor functionProgressive cerebellar ataxiaUpper motor neuron dysfunctionAbnormal pyramidal signPeripheral neuropathyProptosisSupranuclear ophthalmoplegiaGaze-evoked nystagmusDiplopiaDelayed speech and language developmentSpasticityDysarthriaCerebellar atrophyHyperreflexiaDilated fourth ventricleClumsinessSpinocerebellar tract degenerationSkeletal muscle atrophyBabinski signFacial-lingual fasciculationsProgressive gait ataxiaSubstantia nigra gliosisDegeneration of the striatumNeurogenic bladderVocal cord paralysisAbnormal vestibular functionDysphagiaMemory impairmentSleep disturbanceMuscle spasmAbnormality of temperature regulationDistal lower limb amyotrophy

Classification & Codes

Orphanet Code

ORPHA:276238
Machado-Joseph disease type 1
OrphanetORPHA:276238
Treatments0 drug(s)
Symptoms on record34 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO